Perform Another (Advanced) Search

1.  Study Posting (2975) Trial #163210, Vaccines, Nashville, TN
...Study Posting (2975) Trial #163210, Vaccines, Nashville, TN Trial Information HEPATITIS B (HBV) VACCINE Hepatitis B is a disease affecting the liver that is caused by the Hepatitis B virus ...
View Page

2.  Study Posting (4519) Trial #123425, Hepatitis C; Chronic, Mexico City, Mexico
...Study Posting (4519) Trial #123425, Hepatitis C; Chronic, Mexico City, Mexico Trial Information A Study of PEGASYS (Peginterferon alfa-2a (40KD)) Plus Ribavirin in Hemophiliac Patients With Chronic Hepatitis C. Status: Completed Protocol Number: ML16814 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific ...
View Page

3.  Study Posting (4519) Trial #123464, Hepatitis C; Chronic, Caracas, Venezuela
...Study Posting (4519) Trial #123464, Hepatitis C; Chronic, Caracas, Venezuela Trial Information A Study of Roferon-A (Interferon Alfa-2a) in Patients With Chronic Hepatitis C Status: Completed Protocol Number: M23153 Sponsor: F Hoffman-La Roche Ltd Company Division: Pharmaceutical ...
View Page

4.  Study Posting (4519) Trial #123216, Hepatitis C; Chronic, Taipei, Taiwan
...Study Posting (4519) Trial #123216, Hepatitis C; Chronic, Taipei, Taiwan Trial Information A Study of Roferon-A (Interferon Alfa-2a) in Patients With Chronic Hepatitis C Status: Completed Protocol Number: M23153 Sponsor: F Hoffman-La Roche Ltd Company Division: Pharmaceutical ...
View Page

5.  Study Posting (4519) Trial #124919, Hepatitis C; Chronic, Ljubljana, Slovenia
...Study Posting (4519) Trial #124919, Hepatitis C; Chronic, Ljubljana, Slovenia Trial Information A Study of Roferon-A (Interferon Alfa-2a) in Patients With Chronic Hepatitis C Status: Completed Protocol Number: M23153 Sponsor: F Hoffman-La Roche Ltd Company Division: Pharmaceutical ...
View Page

6.  Study Posting (4519) Trial #124639, Hepatitis C; Chronic, Bratislava, Slovakia
...Study Posting (4519) Trial #124639, Hepatitis C; Chronic, Bratislava, Slovakia Trial Information A Study of Roferon-A (Interferon Alfa-2a) in Patients With Chronic Hepatitis C Status: Completed Protocol Number: M23153 Sponsor: F Hoffman-La Roche Ltd Company Division: Pharmaceutical ...
View Page

7.  Study Posting (4519) Trial #156375, Hepatitis C; Chronic, Yakutsk, Russian Federation
...Study Posting (4519) Trial #156375, Hepatitis C; Chronic, Yakutsk, Russian Federation Trial Information A Study of Ribavirin in Combination With PEGASYS (Peginterferon Alfa-2a (40KD))in Patients With Chronic hepatitis C Status: Recruiting Protocol Number: ML16709 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific ...
View Page

8.  Study Posting (4519) Trial #156313, Hepatitis C; Chronic, Volgograd, Russian Federation
...Study Posting (4519) Trial #156313, Hepatitis C; Chronic, Volgograd, Russian Federation Trial Information A Study of Ribavirin in Combination With PEGASYS (Peginterferon Alfa-2a (40KD))in Patients With Chronic hepatitis C Status: Recruiting Protocol Number: ML16709 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific ...
View Page

9.  Study Posting (4519) Trial #156386, Hepatitis C; Chronic, Vladivostok, Russian Federation
...Study Posting (4519) Trial #156386, Hepatitis C; Chronic, Vladivostok, Russian Federation Trial Information A Study of Ribavirin in Combination With PEGASYS (Peginterferon Alfa-2a (40KD))in Patients With Chronic hepatitis C Status: Recruiting Protocol Number: ML16709 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific ...
View Page

10.  Study Posting (4519) Trial #156252, Hepatitis C; Chronic, Ufa, Russian Federation
...Study Posting (4519) Trial #156252, Hepatitis C; Chronic, Ufa, Russian Federation Trial Information A Study of Ribavirin in Combination With PEGASYS (Peginterferon Alfa-2a (40KD))in Patients With Chronic hepatitis C Status: Recruiting Protocol Number: ML16709 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific ...
View Page

11.  Study Posting (4519) Trial #156283, Hepatitis C; Chronic, Tumen, Russian Federation
...Study Posting (4519) Trial #156283, Hepatitis C; Chronic, Tumen, Russian Federation Trial Information A Study of Ribavirin in Combination With PEGASYS (Peginterferon Alfa-2a (40KD))in Patients With Chronic hepatitis C Status: Recruiting Protocol Number: ML16709 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific ...
View Page

12.  Study Posting (4519) Trial #156282, Hepatitis C; Chronic, Tomsk, Russian Federation
...Study Posting (4519) Trial #156282, Hepatitis C; Chronic, Tomsk, Russian Federation Trial Information A Study of Ribavirin in Combination With PEGASYS (Peginterferon Alfa-2a (40KD))in Patients With Chronic hepatitis C Status: Recruiting Protocol Number: ML16709 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific ...
View Page

13.  Study Posting (4519) Trial #156385, Hepatitis C; Chronic, Tjumen, Russian Federation
...Study Posting (4519) Trial #156385, Hepatitis C; Chronic, Tjumen, Russian Federation Trial Information A Study of Ribavirin in Combination With PEGASYS (Peginterferon Alfa-2a (40KD))in Patients With Chronic hepatitis C Status: Recruiting Protocol Number: ML16709 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific ...
View Page

14.  Study Posting (4519) Trial #156383, Hepatitis C; Chronic, Surgut, Russian Federation
...Study Posting (4519) Trial #156383, Hepatitis C; Chronic, Surgut, Russian Federation Trial Information A Study of Ribavirin in Combination With PEGASYS (Peginterferon Alfa-2a (40KD))in Patients With Chronic hepatitis C Status: Recruiting Protocol Number: ML16709 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific ...
View Page

15.  Study Posting (4519) Trial #156280, Hepatitis C; Chronic, Stavropol, Russian Federation
...Study Posting (4519) Trial #156280, Hepatitis C; Chronic, Stavropol, Russian Federation Trial Information A Study of Ribavirin in Combination With PEGASYS (Peginterferon Alfa-2a (40KD))in Patients With Chronic hepatitis C Status: Recruiting Protocol Number: ML16709 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific ...
View Page

16.  Study Posting (4519) Trial #156323, Hepatitis C; Chronic, Soshi, Russian Federation
...Study Posting (4519) Trial #156323, Hepatitis C; Chronic, Soshi, Russian Federation Trial Information A Study of Ribavirin in Combination With PEGASYS (Peginterferon Alfa-2a (40KD))in Patients With Chronic hepatitis C Status: Recruiting Protocol Number: ML16709 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific ...
View Page

17.  Study Posting (4519) Trial #156279, Hepatitis C; Chronic, Smolensk, Russian Federation
...Study Posting (4519) Trial #156279, Hepatitis C; Chronic, Smolensk, Russian Federation Trial Information A Study of Ribavirin in Combination With PEGASYS (Peginterferon Alfa-2a (40KD))in Patients With Chronic hepatitis C Status: Recruiting Protocol Number: ML16709 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific ...
View Page

18.  Study Posting (4519) Trial #156363, Hepatitis C; Chronic, Saratov, Russian Federation
...Study Posting (4519) Trial #156363, Hepatitis C; Chronic, Saratov, Russian Federation Trial Information A Study of Ribavirin in Combination With PEGASYS (Peginterferon Alfa-2a (40KD))in Patients With Chronic hepatitis C Status: Recruiting Protocol Number: ML16709 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific ...
View Page

19.  Study Posting (4519) Trial #156200, Hepatitis C; Chronic, Samara, Russian Federation
...Study Posting (4519) Trial #156200, Hepatitis C; Chronic, Samara, Russian Federation Trial Information A Study of Ribavirin in Combination With PEGASYS (Peginterferon Alfa-2a (40KD))in Patients With Chronic hepatitis C Status: Recruiting Protocol Number: ML16709 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific ...
View Page

20.  Study Posting (4519) Trial #156408, Hepatitis C; Chronic, Salekhard, Russian Federation
...Study Posting (4519) Trial #156408, Hepatitis C; Chronic, Salekhard, Russian Federation Trial Information A Study of Ribavirin in Combination With PEGASYS (Peginterferon Alfa-2a (40KD))in Patients With Chronic hepatitis C Status: Recruiting Protocol Number: ML16709 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific ...
View Page